These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14613509)

  • 21. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia.
    McPherson S; Tafese G; Tafese T; Behaksra SW; Solomon H; Oljira B; Miecha H; Debebe KA; Kebede B; Gebre T; Kebede F; Seife F; Tadesse F; Mammo B; Aseffa A; Solomon AW; Mabey DCW; Marks M; Gadisa E
    EClinicalMedicine; 2023 May; 59():101984. PubMed ID: 37152362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
    Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
    PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi.
    Tafatatha TT; Ngwira BM; Taegtmeyer M; Phiri AJ; Wilson TP; Banda LG; Piston WN; Koole O; Horton J; French N
    Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):393-9. PubMed ID: 25877874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
    Pion SDS; Chesnais CB; Weil GJ; Fischer PU; Missamou F; Boussinesq M
    Lancet Infect Dis; 2017 Jul; 17(7):763-769. PubMed ID: 28372977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
    Beach MJ; Streit TG; Addiss DG; Prospere R; Roberts JM; Lammie PJ
    Am J Trop Med Hyg; 1999 Mar; 60(3):479-86. PubMed ID: 10466981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.
    Ismail MM; Weil GJ; Jayasinghe KS; Premaratne UN; Abeyewickreme W; Rajaratnam HN; Sheriff MH; Perera CS; Dissanaike AS
    Trans R Soc Trop Med Hyg; 1996; 90(6):684-8. PubMed ID: 9015519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment.
    Cao WC; Van der Ploeg CP; Plaisier AP; van der Sluijs IJ; Habbema JD
    Trop Med Int Health; 1997 Apr; 2(4):393-403. PubMed ID: 9171850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.
    Simonsen PE; Magesa SM; Dunyo SK; Malecela-Lazaro MN; Michael E
    Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):462-72. PubMed ID: 15186934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.
    Kazura J; Greenberg J; Perry R; Weil G; Day K; Alpers M
    Am J Trop Med Hyg; 1993 Dec; 49(6):804-11. PubMed ID: 8279647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
    Dembele B; Coulibaly YI; Dolo H; Konate S; Coulibaly SY; Sanogo D; Soumaoro L; Coulibaly ME; Doumbia SS; Diallo AA; Traore SF; Diaman Keita A; Fay MP; Nutman TB; Klion AD
    Clin Infect Dis; 2010 Dec; 51(11):1229-35. PubMed ID: 21039220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivermectin treatment of bancroftian filariasis in Recife, Brazil.
    Coutinho AD; Dreyer G; Medeiros Z; Lopes E; Machado G; Galdino E; Rizzo JA; Andrade LD; Rocha A; Moura I
    Am J Trop Med Hyg; 1994 Mar; 50(3):339-48. PubMed ID: 8147492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
    Ottesen EA; Vijayasekaran V; Kumaraswami V; Perumal Pillai SV; Sadanandam A; Frederick S; Prabhakar R; Tripathy SP
    N Engl J Med; 1990 Apr; 322(16):1113-7. PubMed ID: 2181312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
    Shenoy RK; Dalia S; John A; Suma TK; Kumaraswami V
    Ann Trop Med Parasitol; 1999 Sep; 93(6):643-51. PubMed ID: 10707109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana: follow-up after re-treatment with the combination.
    Dunyo SK; Simonsen PE
    Trans R Soc Trop Med Hyg; 2002; 96(2):189-92. PubMed ID: 12055812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
    de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
    Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria.
    Richards FO; Pam DD; Kal A; Gerlong GY; Onyeka J; Sambo Y; Danboyi J; Ibrahim B; Terranella A; Kumbak D; Dakul A; Lenhart A; Rakers L; Umaru J; Amadiegwu S; Withers PC; Mafuyai H; Jinadu MY; Miri ES; Eigege A
    Ann Trop Med Parasitol; 2005 Mar; 99(2):155-64. PubMed ID: 15814034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya.
    Njenga SM; Wamae CN; Njomo DW; Mwandawiro CS; Molyneux DH
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):1017-24. PubMed ID: 18550135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on the provocative day test effect of ivermectin and albendazole on nocturnal periodic Wuchereria bancrofti microfilaraemia.
    Dunyo SK; Nkrumah FK; Simonsen PE
    Trans R Soc Trop Med Hyg; 1999; 93(6):608-10. PubMed ID: 10717746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.